Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis

Proteomics

Volumn 12, Issue 17, 2012, Pages 2656-2662

  Farias, Alessandro S ^a   Martins de Souza, Daniel ^a,b,c   Guimarães, Leandro ^a   Pradella, Fernando ^a   Moraes, Adriel S ^a   Facchini, Gustavo ^a   Novello, José Camillo ^a   Santos, Leonilda M B ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biomedicine; Inflammation; Mass spectrometry; Neurodegeneration; Protein expression

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; PROTEOME; TUBULIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CATABOLISM; CELL GROWTH; CELL MATURATION; CONTROLLED STUDY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MYELINATION; NERVE DEGENERATION; NERVE INJURY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RAT; REMYELINIZATION; SPINAL CORD; T LYMPHOCYTE ACTIVATION; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; NEURONS; PROTEOME; RATS; RATS, INBRED LEW; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPINAL CORD;

ANIMALIA; RATTUS;

EID: 84865557050     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200044     Document Type: Article

References (27)

1. Hauser, S. L., Oksenberg, J. R., The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006, 52, 61-76.
2. Wekerle, H., Flugel, A., Fugger, L., Schett, G. et al., Autoimmunity's next top models. Nat. Med. 2012, 18, 66-70.
3. Lock, C., Hermans, G., Pedotti, R., Brendolan, A. et al., Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8, 500-508.
4. Mix, E., Meyer-Rienecker, H., Zettl, U. K., Animal models of multiple sclerosis for the development and validation of novel therapies - potential and limitations. J. Neurol. 2008, 255 (Suppl 6), 7-14.
5. Tajouri, L., Mellick, A. S., Tourtellotte, A., Nagra, R. M. et al., An examination of MS candidate genes identified as differentially regulated in multiple sclerosis plaque tissue, using absolute and comparative real-time Q-PCR analysis. Brain Res. Brain Res. Protoc. 2005, 15, 79-91.
6. International Multiple Sclerosis Genetics, C., Hafler, D. A., Compston, A., Sawcer, S. et al., Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 2007, 357, 851-862.
7. Martins-de-Souza, D., Is the word 'biomarker' being properly used by proteomics research in neuroscience? Eur. Arch. Psychiatry Clin. Neurosci. 2010, 260, 561-562.
8. Farias, A. S., Talaisys, R. L., Blanco, Y. C., Lopes, S. C. et al., Regulatory T cell induction during Plasmodium chabaudi infection modifies the clinical course of experimental autoimmune encephalomyelitis. PLoS ONE 2011, 6, e17849.
9. Martins-de-Souza, D., Menezes de Oliveira, B., dos Santos Farias, A., Horiuchi, R. S. et al., The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis. Brief Funct. Genomic. Proteomic. 2007, 6, 70-75.
10. Storey, J. D. A direct approach to false discovery rates. J. R. Stat. Soc. Series B Stat. Methodol. 2002, 64, 479-498.
11. Zhao, L., Mandler, M. D., Yi, H., Feng, Y., Quaking I controls a unique cytoplasmic pathway that regulates alternative splicing of myelin-associated glycoprotein. Proc. Natl. Acad. Sci. USA 2010, 107, 19061-19066.
12. Flugel, A., Berkowicz, T., Ritter, T., Labeur, M. et al., Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 2001, 14, 547-560.
13. Chen, Y., Hancock, W. W., Marks, R., Gonnella, P. et al., Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice. J. Neuroimmunol. 1998, 82, 149-159.
14. Farias, A. S., de la Hoz, C., Castro, F. R., Oliveira, E. C. et al., Nitric oxide and TNFalpha effects in experimental autoimmune encephalomyelitis demyelination. Neuroimmunomodulation 2007, 14, 32-38.
15. Bitsch, A., Schuchardt, J., Bunkowski, S., Kuhlmann, T. et al., Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000, 123 (Pt 6), 1174-1183.
16. Lassmann, H., Multiple sclerosis: is there neurodegeneration independent from inflammation? J. Neurol. Sci. 2007, 259, 3-6.
17. Stefanizzi, I., Canete-Soler, R., Coregulation of light neurofilament mRNA by poly(A)-binding protein and aldolase C: implications for neurodegeneration. Brain Res. 2007, 1139, 15-28.
18. Malmestrom, C., Haghighi, S., Rosengren, L., Andersen, O. et al., Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS. Neurology 2003, 61, 1720-1725.
19. Norgren, N., Edelstam, A., Stigbrand, T., Cerebrospinal fluid levels of neurofilament light in chronic experimental autoimmune encephalomyelitis. Brain Res. Bull. 2005, 67, 264-268.
20. Ebersole, T. A., Chen, Q., Justice, M. J., Artzt, K. The quaking gene product necessary in embryogenesis and myelination combines features of rna binding and signal transduction proteins. Nat. Genet. 1996, 12, 260-265.
21. Gensert, J. M., Goldman, J. E., Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 1997, 19, 197-203.
22. Larocque, D., Pilotte, J., Chen, T., Cloutier, F. et al., Nuclear retention of mbpmrnas in the quaking viable mice. Neuron 2002, 36, 815-829.
23. Chen, Y., Tian, D., Ku, L., Osterhout, D. J. et al., The selective rna-binding protein quaking i (qki) is necessary and sufficient for promoting oligodendroglia differentiation. J. Biol. Chem. 2007, 282, 23553-23560.
24. Dubois-Dalcq, M., Ffrench-Constant, C., Franklin, R. J., Enhancing central nervous system remyelination in multiple sclerosis. Neuron 2005, 48, 9-12.
25. Rosenling, T., Stoop, M. P., Attali, A., Aken, H. V. et al., Profiling and identification of cerebrospinal fluid proteins in a rat EAE model of multiple sclerosis. J. Proteome. Res. 2012, 11, 2048-2060.
26. Blanchet, L., Smolinska, A., Attali, A., Stoop, M. P. et al., Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis. BMC Bioinformatics 2011, 12, 254.
27. Dumont, D., Noben, J. P., Raus, J., Stinissen, P. et al., Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004, 4, 2117-2124.